Sector: Pharmaceuticals

Latest content

“Anticipation is key”: brand protection insight from award-winning Novartis team

Novartis’ global head of legal brand protection, David Lossignol, explains how the 2022 WTR Healthcare and Life Sciences Team of the Year prepares for every scenario.

28 July 2022

WTR Brand Elite analysis: June 2022

Featured in Stock market performance

A rocky month in the stock markets saw the WTR Brand Elite drop eight points through June. The index is now at its lowest value since November 2020.

18 July 2022

Notable trends in trademark litigation and enforcement in China: takeaways from QBPC’s top 10 cases lists

QBPC’s selected cases highlight new methods of calculating damages and compensation, the use of big data, and increased cooperation between authorities and businesses.

13 July 2022

WTR Brand Elite analysis: May 2022

Featured in Stock market performance

The WTR Brand Elite dropped a point in the month ending 31 May, as stock markets around the world returned mixed results. Companies in the energy sector, though, had a strong month.

23 June 2022

Embedding brand in business: lessons from a pharma IP pro

Rachel Cockburn Buhl, head of brand IP at biopharmaceutical group Ferring, reveals how she has expanded the function’s internal expertise to provide wider business support while having a positive budget impact.

22 June 2022

Brand Tracker: January-April 2022

Featured in Prosecution

Filing activity is continuing to decline among 25 of the world’s leading corporations, according to the latest WTR Brand Tracker data.

15 June 2022

Collaboration; information sharing; effective communication – takeaways from WTR Connect: Asia Anti-Counterfeiting

Insights from the WTR Connect: Asia Anti-Counterfeiting event, with expert speakers from brands including Amazon, ASICS, Dyson and LEGO Group.

10 June 2022

General Court rules on complementarity between goods in Classes 3 and 5

While the goods covered by the mark applied for in Class 3 differed from those covered by the earlier mark in Class 5 due to the latter’s therapeutic indication, they shared the same objective and were likely to incorporate the same ingredients.

27 May 2022

WTR Brand Elite analysis: April 2022

Featured in Stock market performance

The WTR Brand Elite slumped seven points in the month ending 30 April, falling to its lowest level since February 2021.

23 May 2022

Post-INTA covid update; INFORM Consumers reaction; bipartisan counterfeit pill legislation – news digest

In our latest round-up, we look at a Swiss blockchain developer accusing Meta of having a “sordid online privacy history” in an infinity logo dispute, the Australian Fashion Council launching a new fashion certification mark, and much more.

10 May 2022

Unlock unlimited access to all WTR content